v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (7,054,531) $ (7,371,012)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,360,305 2,371,442
Share-based compensation expense 2,012,621 1,379,699
Stock issued for special stock bonus 862,230
Issuance of common stock for paying consulting fee 150,000 75,000
Changes in operating assets and liabilities:    
Accounts receivable 22 (131)
Inventory (23,469) (16,301)
Other current assets (32,782) (49,472)
Accrued expenses and other current and long-term liabilities 156,080 173,545
Net cash used in operating activities (2,431,754) (2,575,000)
Cash flows from investing activities:    
Purchase of property and equipment (14,322) (25,950)
Proceeds from disposal of equipment 1,758
Decrease in refundable deposits and other assets 19,861 7,905
Net cash provided by (used in) investing activities 7,297 (18,045)
Cash flows from financing activities:    
Proceeds from Loan agreement 2,812,940
Proceeds from at-the-market offering, net of issuance costs 601,600 719,358
Repayment of convertible notes payable (1,000,000)
Fractional shares paid out in cash for the reverse stock split (260)
Net cash provided by (used in) financing activities 3,414,540 (280,902)
Effect from foreign currency exchange 15,476 204,212
Net increase (decrease) in cash and cash equivalents 1,005,559 (2,669,735)
Cash and cash equivalents at beginning of period 417,353 3,892,919
Cash and cash equivalents at end of period $ 1,422,912 $ 1,223,184